bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.290
0.00 (0.00%)
At close: Jan 7, 2026, 4:00 PM EST
1.320
+0.030 (2.33%)
Pre-market: Jan 8, 2026, 5:11 AM EST
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $5.79 million as of January 8, 2026. Its market cap has decreased by -68.49% in one year.
Market Cap
5.79M
Enterprise Value
-1.19M
1-Year Change
-68.49%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $5.79M, a decrease of -87.13%. That is a compound annual growth rate of -45.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 5.79M | 9.32% |
| Dec 31, 2025 | 5.30M | -62.63% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.72B |
| Johnson & Johnson | 485.47B |
| AbbVie | 389.13B |
| UnitedHealth Group | 302.79B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.36B |
| Novo Nordisk | 230.76B |